• Subscriptions
  • Contact
Documenta Haematologica - Revista Romana de Hematologie
  • About Us
  • Editorial Board
  • Current Issue
  • Archive
    • 2023 Volume 1
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2024 Volume 2
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2025 Volume 3
      • 2025, Volume 3, Issue 1
      • 2025, Volume 3, Issue 2
      • 2025, Volume 3, Issue 3
  • Editorial Process & Peer Review
  • Ethics and Rights
  • How To Submit
Select Page

How I Treat Immune Thrombocytopenia: An Individualized, Patient-Centered Approach

by Catalin | Dec 29, 2025 | 2025 vol. 3 Issue 4

How I Treat Immune Thrombocytopenia: An Individualized, Patient-Centered Approach Cosmin MILITARU, Delia SOARE, Horia BUMBEA Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia resulting from immune-mediated...

Dual Hematologic Malignancies: A Case of Concurrent Accelerated-Phase Chronic Myeloid Leukemia and Ann Arbor Stage III Follicular Lymphoma

by Catalin | Dec 29, 2025 | 2025 vol. 3 Issue 4

Dual Hematologic Malignancies: A Case of Concurrent Accelerated-Phase Chronic Myeloid Leukemia and Ann Arbor Stage III Follicular Lymphoma Agus Jati SUNGGORO, Henry Aldezzia PRATAMA, Kun SALIMAH, Ahmad NURDIANSYAH Objectives: To report an extremely rare case of...

Diverse Presentations of Bleomycin-Induced Lung Injury: A Case Series

by Catalin | Dec 29, 2025 | 2025 vol. 3 Issue 4

Diverse Presentations of Bleomycin-Induced Lung Injury: A Case Series Priyanka CHOUDHARY, Priyanka SONI, Mohit AGARWAL, Omkar Kalidasrao CHOUDHARI, Disha SATYA, Vaishali SHARAI, Gaurav OJHA, Naveen GUPTA, Ajay YADAV, Hemant MALHOTRA Drug-related toxicities are a...

Etiological, Clinical, Diagnostic, and Treatment Particularities of Primary Aggressive Bone Lymphoma

by Catalin | Dec 29, 2025 | 2025 vol. 3 Issue 4

Etiological, Clinical, Diagnostic, and Treatment Particularities of Primary Aggressive Bone Lymphoma Dumitrita URESCU, Vasile MUSTEATA, Maria ROBU, Aliona GOLUB     Primary bone lymphoma (PBL) is a neoplasm of malignant lymphoid cells that presents with one...

Differential Effects of Turmeric (Curcuma longa) and Ginger (Zingiber officinale) Extracts on Malignant and Normal Hematopoietic Cells in the Bone Marrow Microenvironment

by Catalin | Dec 29, 2025 | 2025 vol. 3 Issue 4

Differential Effects of Turmeric (Curcuma longa) and Ginger (Zingiber officinale) Extracts on Malignant and Normal Hematopoietic Cells in the Bone Marrow Microenvironment Magdalina URSU, Nicoleta RADU, Teodora SUPEANU, Viviana ROMAN, Narcisa BABEANU, Gabriel GHIAUR...

Recent Posts

  • How I Treat Immune Thrombocytopenia: An Individualized, Patient-Centered Approach
  • Dual Hematologic Malignancies: A Case of Concurrent Accelerated-Phase Chronic Myeloid Leukemia and Ann Arbor Stage III Follicular Lymphoma
  • Diverse Presentations of Bleomycin-Induced Lung Injury: A Case Series
  • Etiological, Clinical, Diagnostic, and Treatment Particularities of Primary Aggressive Bone Lymphoma
  • Differential Effects of Turmeric (Curcuma longa) and Ginger (Zingiber officinale) Extracts on Malignant and Normal Hematopoietic Cells in the Bone Marrow Microenvironment

Recent Comments

  1. A WordPress Commenter on Hello world!

Copyright © 2025 | Edited by Romanian Society of Hematology